Menu Back to DIA-2015-51st-Annual-Meeting-Develop-Innovate-Advance


DIA 2015 51st Annual Meeting: Develop.  Innovate.  Advance.

The DIA 2015 51st Annual Meeting brings together a global community of life sciences professionals at all levels and across all disciplines all with a common goal to foster innovation that will lead to the development of safe and effective medical products and therapies to patients.

The DIA Annual Meeting provides the best opportunity to meet with people from around the world, share your views and knowledge, network, and build new relationships.

Who should attend?

The DIA Annual Meeting is designed for individuals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, and related medical products.

Learning objectives

  • Provide a global unbiased platform to raise the level of discussion to facilitate innovation that will change the future of health care
  • Provide comprehensive coverage of the full development and life cycle management of process for all health care products
  • Offer a holistic and integrated approach to the development life cycle management of regulated health care products

Program Committee

  • Christopher P. Austin, MD
    Christopher P. Austin, MD Director, National Center for Advancing Translational Sciences National Institutes of Health (NIH), United States
  • Michael  Rosenblatt, MD
    Michael Rosenblatt, MD Executive Vice President and Chief Medical Officer Merck & Co., Inc., United States
  • J. Lynn  Bass, PharmD, RPh
    J. Lynn Bass, PharmD, RPh Director, Medical Affairs Jazz Pharmaceuticals, United States
  • Daniel M. Bollag, PhD
    Daniel M. Bollag, PhD Senior Vice President, Regulatory Affairs and Quality Ariad Pharmaceuticals Inc., United States
  • Linda F. Bowen, MS, RAC
    Linda F. Bowen, MS, RAC Head, US Regulatory Policy and Intelligence Sanofi, United States
  • Jonca C. Bull, MD
    Jonca C. Bull, MD Assistant Commissioner for Minority Health, Office of the Commissioner FDA, United States
  • Bill  Byrom, PhD
    Bill Byrom, PhD Senior Director, Product Innovation ICON plc, United Kingdom
  • Joy A. Cavagnaro, PhD, RAC
    Joy A. Cavagnaro, PhD, RAC President Access BIO, United States
  • Karla  Childers, MS
    Karla Childers, MS Senior Director, Strategic Projects, Office of the Chief Medical Officer Johnson and Johnson, United States
  • Leah  Christl, PhD
    Leah Christl, PhD Associate Director for Therapeutic Biologics, OND, CDER FDA, United States
  • Betsy  Fallen, RN
    Betsy Fallen, RN Consultant BAFallen Consulting, LLC, United States
  • Ron D. Fitzmartin, PhD, MBA
    Ron D. Fitzmartin, PhD, MBA Senior Advisor, Data Standards Program, Office of Strategic Programs, CDER FDA, United States
  • Michael  Folkendt, MS
    Michael Folkendt, MS Associate Director, Office of Programs and Regulatory Operations, OPQ, CDER FDA, United States
  • Elizabeth E. Garrard, PharmD
    Elizabeth E. Garrard, PharmD Senior Director, Safety Risk Management United Therapeutics Corporation, United States
  • Jonathan  Haddad, MPH, MT
    Jonathan Haddad, MPH, MT Director, Clinical Statistics GlaxoSmithKline, United States
  • Martin  Harvey Allchurch, LLM
    Martin Harvey Allchurch, LLM Principal International Affairs Officer European Medicines Agency, European Union , United Kingdom
  • Jonathan S. Helfgott, MS
    Jonathan S. Helfgott, MS Director, Global Regulatory Affairs Stage 2 Innovations, United States
  • Deborah J. Henderson, MSN
    Deborah J. Henderson, MSN Head, Global Regulatory Policy Merck & Co., Inc., United States
  • Rima  Izem, PhD
    Rima Izem, PhD Lead Mathematical Statistician, Office of Translational Science, CDER FDA, United States
  • Janet  Jenkins-Showalter
    Janet Jenkins-Showalter Head, US Regulatory Policy Genentech, A Member of the Roche Group, United States
  • John  Kamp, JD, PhD
    John Kamp, JD, PhD Attorney at Law; Executive Director Wiley Rein LLP; Coalition For Healthcare Communication, United States
  • Ellen  Kelso
    Ellen Kelso Executive Director Chesapeake IRB, United States
  • Lisa Palladino Kim, MS
    Lisa Palladino Kim, MS Faculty Rutgers, The State University of New Jersey, United States
  • Lynn  King, MHA
    Lynn King, MHA Senior Director, Clinical Operations TKL Research, Inc., United States
  • Agnes V. Klein, DrPH, MD
    Agnes V. Klein, DrPH, MD Director, Evaluation of Radiopharmaceuticals and Biotherapeutic Products Health Canada, Canada
  • Stephen  Knowles, MD, MRCP
    Stephen Knowles, MD, MRCP Senior Director, Global Patient Safety Eli Lilly and Company, United States
  • Mark A. Kryah, PMP
    Mark A. Kryah, PMP Senior Advisor/COO, Pharmaceutical Project Management Eli Lilly and Company, United States
  • JeanMarie  Markham
    JeanMarie Markham Chief Executive Officer Clinlogix LLC, United States
  • Philomena  McArthur, JD
    Philomena McArthur, JD Senior Director, Regulatory Advertising and Promotion and Healthcare Compliance Johnson & Johnson International, United States
  • Ann  Meeker-O'Connell, MS
    Ann Meeker-O'Connell, MS Head, Risk Management and External Engagement, Bioresearch Quality & Compliance Janssen Pharmaceuticals, Inc., United States
  • Jon  Meyer, MBA, MSc
    Jon Meyer, MBA, MSc Co-Founder and Managing Member Life Science Strategy Group, LLC, United States
  • Mary Stober Murray, MBA
    Mary Stober Murray, MBA Associate Director, Advocacy Bristol-Myers Squibb Company, United States
  • Bob  Muzerall
    Bob Muzerall Vice President, Sales and Sales Training ForeignExchange Translations, United States
  • Nancy Bradish Myers, JD
    Nancy Bradish Myers, JD President Catalyst Healthcare Consulting, Inc, United States
  • Jane E. Myles, MS
    Jane E. Myles, MS Global Head, Recruitment Strategy Genentech, A Member of the Roche Group, United States
  • Roger  Nosal, MA, MS
    Roger Nosal, MA, MS Vice President and Head, Global CMC Pfizer Inc , United States
  • Pradip  Paul, MD, MS
    Pradip Paul, MD, MS Consultant Strategic Pharmacovigilance and Risk Management, United States
  • Kirsten H. Paulson, MS, RAC
    Kirsten H. Paulson, MS, RAC Senior Director, Global CMC Medical Devices Pfizer Inc, United States
  • Julia  Petses, PharmD
    Julia Petses, PharmD Director, Medical Information Services Metabolism Sanofi, United States
  • Christine  Pierre, RN
    Christine Pierre, RN President Society for Clinical Research Sites, United States
  • James E. Polli, PhD
    James E. Polli, PhD Prof, Dept Pharmaceutical Sciences; Ralph F. Shangraw/Noxell Endowed Chair University of Maryland School of Pharmacy, United States
  • Sarah  Pope Miksinski, PhD
    Sarah Pope Miksinski, PhD Acting Director, Office of New Drug Products, OPQ, CDER FDA, United States
  • Badri  Rengarajan, DrMed
    Badri Rengarajan, DrMed Study Physician, Medical Affairs Actelion, United States
  • Matthew D. Rotelli, PhD
    Matthew D. Rotelli, PhD Director, Global PK/PD and Pharmacometrics, Bio-Medicines Eli Lilly and Company, United States
  • Leslie M. Sam
    Leslie M. Sam Director, Global Quality Systems, Safety, Efficacy and Customer Information Eli Lilly and Company, United States
  • Abdul J. Sankoh, PhD, MA, MS
    Abdul J. Sankoh, PhD, MA, MS Vice President, Biostatistics and Clinical Informatics Synageva Biopharma, United States
  • Suzanne  Sensabaugh, MBA, MS
    Suzanne Sensabaugh, MBA, MS President and Principal Consultant HartmannWillner LLC, United States
  • Ashley F. Slagle, PhD, MS
    Ashley F. Slagle, PhD, MS Endpoints Reviewer, Study Endpoints and Labeling Development, OND, CDER FDA, United States
  • Nancy  Smerkanich
    Nancy Smerkanich Educational Liaison/Regulatory Science Doctoral Candidate University of Southern California, United States
  • Maureen  Smith, MEd
    Maureen Smith, MEd Patient Advocate / Secretary Canadian Organization For Rare Disorders (CORD), Canada
  • William B. Smith, MD
    William B. Smith, MD President VRG/New Orleans Center For Clinical Research, United States
  • Ling  Su, PhD
    Ling Su, PhD Strategic Advisor, Life Sciences Sidley Austin LLP, China
  • Sameer  Thapar, PharmD
    Sameer Thapar, PharmD Professor and Advisor, Biopharma Educational Initiative, Drug Safety and PV Rutgers, The State University of New Jersey, United States
  • Toshiyoshi  Tominaga
    Toshiyoshi Tominaga Associate Executive Director for International Programs Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Linda Fossati Wood, MPH, RN
    Linda Fossati Wood, MPH, RN President MedWrite, Inc., United States
Load More

Contact us

DIA Americas
800 Enterprise Road, Suite 200
Horsham, PA 19044-3595, USA
Phone: +1 215 442 6100
Fax: +1 215 442 6199

Questions related to the DIA 2015 51st Annual Meeting Program? Contact:

Ways to register

Registration override should work.